Stereochemically enriched compositions for delivery of nucleic acids
US-2015376144-A1 · Dec 31, 2015 · US
Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
US9102632B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9102632-B2 |
| Application number | US-201314109225-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 17, 2013 |
| Priority date | Mar 5, 2008 |
| Publication date | Aug 11, 2015 |
| Grant date | Aug 11, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The treatment of diabetes and associated pathologies is achieved by administering the pyrazinone compounds of formula (I)
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for treating diabetes associated with lack of insulin production or for treating type II diabetes, comprising administering to a subject in need thereof an effective amount of a compound of formula (I), or a racemic form, tautomer, enantiomer, diastereomer, epimer or polymorph thereof, or a mixture thereof, or a pharmaceutically acceptable salt thereof…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9102632B2 cover?
- The treatment of diabetes and associated pathologies is achieved by administering the pyrazinone compounds of formula (I)
- Who is the assignee on this patent?
- Merck Patent Gmbh
- What technology area does this patent fall under?
- Primary CPC classification C07D241/08. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).